Needham, MA, United States of America

Aaron Deykin

This inventor holds 2 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Biogen Ma Inc., Biogen, Incorporated. Active years: 2015-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aaron Deykin. Retrieved from https://idiyas.com/inventor/aaron-deykin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2019

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Aaron Deykin

Introduction

Aaron Deykin is an accomplished inventor based in Needham, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of multiple sclerosis (MS). With a total of 2 patents, Deykin's work focuses on improving patient outcomes through innovative methods.

Latest Patents

Deykin's latest patents include a method for reducing flu-like symptoms associated with intramuscular administration of interferon. This invention provides a systematic approach to treating MS patients by administering interferon according to an escalating dosing regimen. The regimen spans four weeks, with the first three weeks involving gradually increasing doses, culminating in a full therapeutically effective dose in the fourth week. This method not only aims to alleviate flu-like symptoms but also includes titration packages to ensure patient compliance with the changing dosage.

Career Highlights

Throughout his career, Aaron Deykin has worked with notable companies in the biotechnology sector. He has been associated with Biogen, Incorporated and Biogen MA Inc., where he has contributed to advancements in therapeutic treatments.

Conclusion

Aaron Deykin's innovative approaches in the treatment of multiple sclerosis highlight his dedication to improving patient care. His patents reflect a commitment to developing effective medical solutions that address the challenges faced by patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…